Ameritas Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Sell
52,746
-1,994
-4% -$52.2K 0.03% 556
2026
Q1
$1.54M Sell
54,740
-211
-0.4% -$5.62K 0.05% 442
2025
Q4
$1.37M Sell
54,951
-598
-1% -$15.1K 0.04% 482
2025
Q3
$1.42M Sell
55,549
-1,101
-2% -$27.2K 0.04% 468
2025
Q2
$1.37M Sell
56,650
-289
-0.5% -$6.74K 0.04% 498
2025
Q1
$1.44M Sell
56,939
-2,372
-4% -$62.1K 0.05% 461
2024
Q4
$1.57M Sell
59,311
-2,128
-3% -$57.7K 0.05% 447
2024
Q3
$1.78M Sell
61,439
-3,209
-5% -$93.6K 0.06% 390
2024
Q2
$1.81M Sell
64,648
-1,382
-2% -$38K 0.06% 342
2024
Q1
$1.83M Sell
66,030
-1,608
-2% -$44.6K 0.06% 369
2023
Q4
$1.95M Sell
67,638
-2,771
-4% -$83.8K 0.07% 314
2023
Q3
$2.34M Sell
70,409
-1,814
-3% -$64.1K 0.09% 218
2023
Q2
$2.65M Sell
72,223
-872
-1% -$33.9K 0.1% 193
2023
Q1
$2.98M Buy
73,095
+347
+0.5% +$15K 0.12% 166
2022
Q4
$3.3M Sell
72,748
-1,003
-1% -$48.1K 0.13% 144
2022
Q3
$3.23M Sell
73,751
-697
-0.9% -$33.9K 0.14% 128
2022
Q2
$3.9M Sell
74,448
-2,324
-3% -$118K 0.17% 94
2022
Q1
$3.97M Sell
76,772
-1,848
-2% -$95.9K 0.14% 126
2021
Q4
$4.64M Sell
78,620
-4,148
-5% -$206K 0.16% 101
2021
Q3
$3.56M Buy
82,768
+4,981
+6% +$221K 0.13% 138
2021
Q2
$3.04M Sell
77,787
-714
-0.9% -$27.8K 0.11% 179
2021
Q1
$2.84M Sell
78,501
-4,091
-5% -$145K 0.11% 188
2020
Q4
$3.04M Sell
82,592
-10,573
-11% -$388K 0.14% 149
2020
Q3
$3.24M Sell
93,165
-4,271
-4% -$150K 0.15% 119
2020
Q2
$3.02M Sell
97,436
-1,826
-2% -$62K 0.14% 121
2020
Q1
$3.07M Sell
99,262
-2,179
-2% -$74.2K 0.17% 91
2019
Q4
$3.77M Sell
101,441
-1,111
-1% -$39.6K 0.17% 90
2019
Q3
$3.5M Sell
102,552
-3,052
-3% -$111K 0.16% 106
2019
Q2
$4.34M Sell
105,604
-1,462
-1% -$58.1K 0.2% 76
2019
Q1
$4.31M Sell
107,066
-4,266
-4% -$171K 0.2% 71
2018
Q4
$4.61M Sell
111,332
-4,232
-4% -$176K 0.25% 58
2018
Q3
$4.83M Sell
115,564
-2,664
-2% -$103K 0.22% 64
2018
Q2
$4.07M Sell
118,228
-14,572
-11% -$498K 0.2% 83
2018
Q1
$4.47M Sell
132,800
-6,124
-4% -$211K 0.21% 67
2017
Q4
$4.7M Sell
138,924
-6,154
-4% -$210K 0.21% 76
2017
Q3
$4.67M Buy
145,078
+527
+0.4% +$16.9K 0.22% 62
2017
Q2
$4.61M Sell
144,551
-3,595
-2% -$113K 0.22% 63
2017
Q1
$4.81M Sell
148,146
-8,076
-5% -$255K 0.24% 62
2016
Q4
$4.81M Hold
156,222
0.24% 61
2016
Q3
$5.02M Sell
156,222
-63,941
-29% -$2.14M 0.27% 49
2016
Q2
$7.35M Buy
220,163
+6,180
+3% +$197K 0.48% 33
2016
Q1
$6.02M Sell
213,983
-1,487
-0.7% -$42.5K 0.4% 41
2015
Q4
$6.6M Buy
215,470
+1,559
+0.7% +$49K 0.45% 35
2015
Q3
$6.37M Buy
213,911
+455
+0.2% +$14.6K 0.46% 29
2015
Q2
$6.79M Buy
213,456
+1,005
+0.5% +$32.8K 0.45% 35
2015
Q1
$7.01M Sell
212,451
-3,311
-2% -$105K 0.46% 34
2014
Q4
$6.38M Buy
215,762
+9,749
+5% +$280K 0.44% 37
2014
Q3
$5.78M Sell
206,013
-8,423
-4% -$236K 0.41% 39
2014
Q2
$6.04M Sell
214,436
-1,092
-0.5% -$31.1K 0.43% 35
2014
Q1
$6.57M Sell
215,528
-10,059
-4% -$300K 0.52% 30
2013
Q4
$6.55M Buy
225,587
+5,507
+3% +$160K 0.52% 30
2013
Q3
$6M Buy
220,080
+158,123
+255% +$4.3M 0.56% 22
2013
Q2
$1.65M Buy
+61,957
New +$1.71M 0.45% 86

Other funds holding PFE

Ameritas Investment Partners's PFE Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Pfizer (PFE) stake by 3.6% in Q2 2026, selling an estimated $52.2K and leaving 52,746 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #556.

Ameritas Investment Partners first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.35M in Q2 2016. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ameritas Investment Partners held 52,746 shares of Pfizer worth $1.27M as of Q2 2026.
  • Ameritas Investment Partners sold 1,994 Pfizer shares in Q2 2026, an estimated $52.2K.
  • Pfizer made up 0.03% of Ameritas Investment Partners's portfolio in Q2 2026, its #556 holding.
  • Ameritas Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Ameritas Investment Partners's Pfizer position peaked at $7.35M in Q2 2016.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.